Notably, the ability of short acting GLP-1 RAs to prevent postprandial glucose excursions is greatly diminished for meals when they are not administered (282)
Contraindications: allergy to ingredients, certain liver/kidney conditions, or B12 sensitivity.
Testosterone and Retatrutide: Hormonal Foundation Testosterone forms the foundation of any serious hormone optimization protocol, and its importance becomes even greater during aggressive weight loss
Look for the leading indicators: changes in appetite, satiety signals, and subject feedback
(March 2025) MOUNJARO (tirzepatide) Injection, for subcutaneous use (2022) Zepbound (tirzepatide) Injection, for subcutaneous use (2022) Tirzepatide Once Weekly for the Treatment of Obesity (June 4, 2022)